Federal Register - February 12, 2021
Versión en texto ¿Qué es?Dateas es un sitio independiente no afiliado a entidades gubernamentales. La fuente de los documentos PDF aquí publicados es la entidad gubernamental indicada en cada uno de ellos. Las versiones en texto son transcripciones no oficiales que realizamos para facilitar el acceso y la búsqueda de información, pero pueden contener errores o no estar completas.
Fuente: Federal Register
9308
Federal Register / Vol. 86, No. 28 / Friday, February 12, 2021 / Proposed Rules
substantial changes to the amendment.
IPCB also adopted minor administrative changes such as alphabetizing compound names and adopting IUPAC
names for some compounds listed at 35
IAC 211.7150.
III. EPAs Analysis of the Proposed SIP
Revision In 2014, EPA received a petition requesting that cis-1,1,1,4,4,4hexafluorobut-2-ene be exempted from VOC control based on its low reactivity, using ethane as a benchmark. Based on the mass maximum incremental reactivity value for the compound being less than that of ethane, EPA concluded that this compound makes negligible contributions to tropospheric ozone formation. Additionally, EPA
considered risks not related to tropospheric ozone associated with currently allowed uses of the chemical to be acceptable. As a result, on November 28, 2018, EPA responded to the petition by amending 40 CFR
51.100s to exclude this chemical compound from the definition of VOC
for purposes of preparing SIPs to attain the national ambient air quality standard for ozone under title I of the CAA. See 83 FR 61127 Nov. 28, 2018.
EPAs action became effective on January 28, 2019.
By excluding cis-1,1,1,4,4,4hexafluorobut-2-ene from the definition of VOM at 35 IAC 211.7150, Illinois proposed SIP revision is consistent with EPAs action amending the definition of VOC at 40 CFR 51.100s.
IV. What action is EPA taking?
EPA is proposing to approve the revision to the Illinois SIP at 35 IAC
211.7150 submitted on October 20, 2020. The proposed approval of the revision meets the criteria of the CAA
and applicable Federal regulations.
V. Incorporation by Reference In this rule, EPA is proposing to include in a final EPA rule regulatory text that includes incorporation by reference. In accordance with requirements of 1 CFR 51.5, EPA is proposing to incorporate by reference revisions to 35 IAC 211.7150 Volatile Organic Material VOM or Volatile Organic Compound VOC, effective August 18, 2020. EPA has made, and will continue to make, these documents generally available through www.regulations.gov and at the EPA
Region 5 Office please contact the person identified in the FOR FURTHER
INFORMATION CONTACT section of this preamble for more information.
VerDate Sep<11>2014
17:15 Feb 11, 2021
Jkt 253001
VI. Statutory and Executive Order Reviews Under the CAA the Administrator is required to approve a SIP submission that complies with the provisions of the CAA and applicable Federal regulations.
42 U.S.C. 7410k; 40 CFR 52.02a.
Thus, in reviewing SIP submissions, EPAs role is to approve state choices, provided that they meet the criteria of the CAA. Accordingly, this action merely approves state law as meeting Federal requirements and does not impose additional requirements beyond those imposed by state law. For that reason, this action:
Is not a significant regulatory action subject to review by the Office of Management and Budget under Executive Orders 12866 58 FR 51735, October 4, 1993 and 13563 76 FR 3821, January 21, 2011;
Is not an Executive Order 13771 82
FR 9339, February 2, 2017 regulatory action because SIP approvals are exempted under Executive Order 12866;
Does not impose an information collection burden under the provisions of the Paperwork Reduction Act 44
U.S.C. 3501 et seq.;
Is certified as not having a significant economic impact on a substantial number of small entities under the Regulatory Flexibility Act 5
U.S.C. 601 et seq.;
Does not contain any unfunded mandate or significantly or uniquely affect small governments, as described in the Unfunded Mandates Reform Act of 1995 Pub. L. 1044;
Does not have federalism implications as specified in Executive Order 13132 64 FR 43255, August 10, 1999;
Is not an economically significant regulatory action based on health or safety risks subject to Executive Order 13045 62 FR 19885, April 23, 1997;
Is not a significant regulatory action subject to Executive Order 13211 66 FR
28355, May 22, 2001;
Is not subject to requirements of Section 12d of the National Technology Transfer and Advancement Act of 1995 15 U.S.C. 272 note because application of those requirements would be inconsistent with the Clean Air Act;
and Does not provide EPA with the discretionary authority to address, as appropriate, disproportionate human health or environmental effects, using practicable and legally permissible methods, under Executive Order 12898
59 FR 7629, February 16, 1994.
In addition, the SIP is not approved to apply on any Indian reservation land or in any other area where EPA or an
PO 00000
Frm 00005
Fmt 4702
Sfmt 4702
Indian tribe has demonstrated that a tribe has jurisdiction. In those areas of Indian country, the rule does not have tribal implications and will not impose substantial direct costs on tribal governments or preempt tribal law as specified by Executive Order 13175 65
FR 67249, November 9, 2000.
List of Subjects in 40 CFR Part 52
Environmental protection, Air pollution control, Incorporation by reference, Intergovernmental relations, Ozone, Reporting and recordkeeping requirements, Volatile organic compounds.
Dated: February 4, 2021.
Cheryl Newton, Acting Regional Administrator, Region 5.
FR Doc. 202102744 Filed 21121; 8:45 am BILLING CODE 656050P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
42 CFR Part 100
RIN 0906AB24
National Vaccine Injury Compensation Program: Revisions to the Vaccine Injury Table; Notice of Proposed Rulemaking; Public Comment Period;
Delay of Effective Date Health Resources and Services Administration HRSA, Department of Health and Human Services HHS.
ACTION: Notice of proposed rulemaking;
proposed delay of effective date; request for comments.
AGENCY:
In accordance with the Presidential directive as expressed in the memorandum of January 20, 2021, from the Assistant to the President and Chief of Staff, entitled Regulatory Freeze Pending Review, this action proposes, following a brief public comment period, to further delay until April 23, 2021, the effective date of the rule entitled National Vaccine Injury Compensation Program: Revisions to the Vaccine Injury Table, published in the Federal Register on January 21, 2021.
That final rule is scheduled to take effect on February 22, 2021. HHS seeks comments on this proposed delay, which would allow it additional opportunity for review and consideration of the new rule.
DATES: Written comments and related material to this proposed rule must be received to the online docket via https
www.regulations.gov on or before February 16, 2021.
ADDRESSES: You may submit written comments electronically by the SUMMARY:
E:FRFM12FEP1.SGM
12FEP1